Corvus Pharmaceuticals, Inc. (CRVS)
NASDAQ: CRVS · Real-Time Price · USD
8.81
0.00 (0.00%)
At close: Dec 5, 2025, 4:00 PM EST
9.08
+0.27 (3.06%)
After-hours: Dec 5, 2025, 7:01 PM EST
Corvus Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Selling, General & Admin | 9.11 | 8.16 | 6.8 | 7.51 | 9.28 | 11.93 | |
| Research & Development | 29.75 | 19.39 | 16.53 | 24.47 | 29.12 | 31.83 | |
| Operating Expenses | 38.86 | 27.55 | 23.33 | 31.98 | 38.4 | 43.76 | |
| Operating Income | -38.86 | -27.55 | -23.33 | -31.98 | -38.4 | -43.76 | |
| Interest & Investment Income | 2.41 | 1.82 | 1.58 | 0.65 | - | 0.54 | |
| Earnings From Equity Investments | -3.43 | -3.2 | -5.28 | -10.01 | -4.83 | -0.23 | |
| Other Non Operating Income (Expenses) | 24.79 | -33.38 | - | - | -0.02 | - | |
| EBT Excluding Unusual Items | -15.08 | -62.3 | -27.03 | -41.33 | -43.24 | -43.45 | |
| Gain (Loss) on Sale of Assets | 0.01 | 0.01 | - | 0.02 | - | 37.46 | |
| Pretax Income | -15.08 | -62.29 | -27.03 | -41.31 | -43.24 | -6 | |
| Net Income | -15.08 | -62.29 | -27.03 | -41.31 | -43.24 | -6 | |
| Net Income to Common | -15.08 | -62.29 | -27.03 | -41.31 | -43.24 | -6 | |
| Shares Outstanding (Basic) | 75 | 61 | 48 | 47 | 42 | 29 | |
| Shares Outstanding (Diluted) | 75 | 61 | 48 | 47 | 42 | 29 | |
| Shares Change (YoY) | 34.14% | 26.99% | 3.16% | 11.23% | 41.98% | 0.44% | |
| EPS (Basic) | -0.20 | -1.02 | -0.56 | -0.89 | -1.03 | -0.20 | |
| EPS (Diluted) | -0.56 | -1.02 | -0.56 | -0.89 | -1.03 | -0.20 | |
| Free Cash Flow | -32.22 | -25.42 | -23.97 | -27.29 | -36.72 | -34.85 | |
| Free Cash Flow Per Share | -0.43 | -0.42 | -0.50 | -0.59 | -0.88 | -1.18 | |
| EBITDA | -38.76 | -27.46 | -23.18 | -31.61 | -37.94 | -43.13 | |
| D&A For EBITDA | 0.1 | 0.09 | 0.15 | 0.37 | 0.46 | 0.63 | |
| EBIT | -38.86 | -27.55 | -23.33 | -31.98 | -38.4 | -43.76 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.